Dioscin alleviates hashimoto’s thyroiditis by regulating the SUMOylation of IRF4 to promote CD4+CD25+Foxp3+ treg cell differentiation

Authors :: Wen Weibo
Sun Yumeng
Qiao Nan
Cao Yongjun
Jin Xiaowen
Source :: Autoimmunity. 54:51-59
Publication Year :: 2020
Publisher :: Informa UK Limited, 2020.
Abstract: Dioscin has been used as a treatment for Hashimoto’s thyroiditis (HT) in China. However, the molecular mechanisms governing the modes of action of dioscin have not been elucidated. In this study, f...

Full Text Access

Tools